228 related articles for article (PubMed ID: 34328815)
1. Chronic Sildenafil Therapy in the ZSF1 Obese Rat Model of Metabolic Syndrome and Heart Failure With Preserved Ejection Fraction.
Leite S; Moreira-Costa L; Cerqueira R; Sousa-Mendes C; Angélico-Gonçalves A; Fontoura D; Vasques-Nóvoa F; Leite-Moreira AF; Lourenço AP
J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):690-701. PubMed ID: 34328815
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction.
Moreira-Costa L; Tavares-Silva M; Almeida-Coelho J; Gonçalves A; Trindade F; Vasques-Nóvoa F; Sousa-Mendes C; Leite S; Vitorino R; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
Eur J Pharmacol; 2024 Mar; 966():176336. PubMed ID: 38272343
[TBL] [Abstract][Full Text] [Related]
3. Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction.
Leite S; Rodrigues S; Tavares-Silva M; Oliveira-Pinto J; Alaa M; Abdellatif M; Fontoura D; Falcão-Pires I; Gillebert TC; Leite-Moreira AF; Lourenço AP
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1648-54. PubMed ID: 26408538
[TBL] [Abstract][Full Text] [Related]
4. Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
Salah EM; Bastacky SI; Jackson EK; Tofovic SP
J Cardiovasc Pharmacol; 2018 Apr; 71(4):205-214. PubMed ID: 29620605
[TBL] [Abstract][Full Text] [Related]
5. Spectral transfer function analysis of respiratory hemodynamic fluctuations predicts end-diastolic stiffness in preserved ejection fraction heart failure.
Abdellatif M; Leite S; Alaa M; Oliveira-Pinto J; Tavares-Silva M; Fontoura D; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H4-13. PubMed ID: 26475584
[TBL] [Abstract][Full Text] [Related]
6. Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction.
Leite S; Cerqueira RJ; Ibarrola J; Fontoura D; Fernández-Celis A; Zannad F; Falcão-Pires I; Paulus WJ; Leite-Moreira AF; Rossignol P; López-Andrés N; Lourenço AP
Circ Heart Fail; 2019 Jul; 12(7):e005596. PubMed ID: 31525070
[TBL] [Abstract][Full Text] [Related]
7. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model.
Hamdani N; Franssen C; Lourenço A; Falcão-Pires I; Fontoura D; Leite S; Plettig L; López B; Ottenheijm CA; Becher PM; González A; Tschöpe C; Díez J; Linke WA; Leite-Moreira AF; Paulus WJ
Circ Heart Fail; 2013 Nov; 6(6):1239-49. PubMed ID: 24014826
[TBL] [Abstract][Full Text] [Related]
8. Adenosine Kinase Inhibition Augments Conducted Vasodilation and Prevents Left Ventricle Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
Davila A; Tian Y; Czikora I; Li J; Su H; Huo Y; Patel V; Robinson V; Kapuku G; Weintraub N; Bagi Z
Circ Heart Fail; 2019 Aug; 12(8):e005762. PubMed ID: 31525084
[TBL] [Abstract][Full Text] [Related]
9. Echocardiography and invasive hemodynamics during stress testing for diagnosis of heart failure with preserved ejection fraction: an experimental study.
Leite S; Oliveira-Pinto J; Tavares-Silva M; Abdellatif M; Fontoura D; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1556-63. PubMed ID: 25862827
[TBL] [Abstract][Full Text] [Related]
10. Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction.
Neves JS; Leite AR; Conceição G; Gonçalves A; Borges-Canha M; Vale C; Von-Hafe M; Martins D; Miranda-Silva D; Leite S; Rocha-Oliveira E; Sousa-Mendes C; Chaves J; Lourenço IM; Grijota-Martínez C; Bárez-López S; Miranda IM; Almeida-Coelho J; Vasques-Nóvoa F; Carvalho D; Lourenço A; Falcão-Pires I; Leite-Moreira A
Thyroid; 2023 Aug; 33(8):983-996. PubMed ID: 37140469
[No Abstract] [Full Text] [Related]
11. Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction.
Nguyen ITN; Brandt MM; van de Wouw J; van Drie RWA; Wesseling M; Cramer MJ; de Jager SCA; Merkus D; Duncker DJ; Cheng C; Joles JA; Verhaar MC
PLoS One; 2020; 15(5):e0232399. PubMed ID: 32374790
[TBL] [Abstract][Full Text] [Related]
12. Treatment With Treprostinil and Metformin Normalizes Hyperglycemia and Improves Cardiac Function in Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
Wang L; Halliday G; Huot JR; Satoh T; Baust JJ; Fisher A; Cook T; Hu J; Avolio T; Goncharov DA; Bai Y; Vanderpool RR; Considine RV; Bonetto A; Tan J; Bachman TN; Sebastiani A; McTiernan CF; Mora AL; Machado RF; Goncharova EA; Gladwin MT; Lai YC
Arterioscler Thromb Vasc Biol; 2020 Jun; 40(6):1543-1558. PubMed ID: 32268788
[TBL] [Abstract][Full Text] [Related]
13. The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15.
Stolina M; Luo X; Dwyer D; Han CY; Chen R; Zhang Y; Xiong Y; Chen Y; Yin J; Shkumatov A; Ason B; Hale C; Véniant MM
PLoS One; 2020; 15(8):e0231234. PubMed ID: 32804947
[TBL] [Abstract][Full Text] [Related]
14. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
[TBL] [Abstract][Full Text] [Related]
15. Acetylation and phosphorylation changes to cardiac proteins in experimental HFpEF due to metabolic risk reveal targets for treatment.
Koser F; Hobbach AJ; Abdellatif M; Herbst V; Türk C; Reinecke H; Krüger M; Sedej S; Linke WA
Life Sci; 2022 Nov; 309():120998. PubMed ID: 36179815
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study.
Belyavskiy E; Ovchinnikov A; Potekhina A; Ageev F; Edelmann F
BMC Cardiovasc Disord; 2020 Sep; 20(1):408. PubMed ID: 32912157
[TBL] [Abstract][Full Text] [Related]
17. Renal injury in relation to obesity and the additive effect of hypertension in female and male obese and lean ZSF1 rats.
Nguyen ITN; Cramer MJ; Joles JA; Verhaar MC
Am J Physiol Renal Physiol; 2023 Jul; 325(1):F73-F86. PubMed ID: 37227224
[TBL] [Abstract][Full Text] [Related]
18. Effects of homoarginine supplementation on heart and skeletal muscle of rats with heart failure with preserved ejection fraction.
Büttner P; Adams V; Werner S; Ossmann S; Besler C; Schwedhelm E; Thiele H
ESC Heart Fail; 2022 Dec; 9(6):4348-4351. PubMed ID: 36043453
[TBL] [Abstract][Full Text] [Related]
19. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
Redfield MM; Chen HH; Borlaug BA; Semigran MJ; Lee KL; Lewis G; LeWinter MM; Rouleau JL; Bull DA; Mann DL; Deswal A; Stevenson LW; Givertz MM; Ofili EO; O'Connor CM; Felker GM; Goldsmith SR; Bart BA; McNulty SE; Ibarra JC; Lin G; Oh JK; Patel MR; Kim RJ; Tracy RP; Velazquez EJ; Anstrom KJ; Hernandez AF; Mascette AM; Braunwald E;
JAMA; 2013 Mar; 309(12):1268-77. PubMed ID: 23478662
[TBL] [Abstract][Full Text] [Related]
20. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
Hoendermis ES; Liu LC; Hummel YM; van der Meer P; de Boer RA; Berger RM; van Veldhuisen DJ; Voors AA
Eur Heart J; 2015 Oct; 36(38):2565-73. PubMed ID: 26188003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
